A New Formula For Echo-Doppler Estimation of Right Ventricular Systolic Pressure

Pepi, Mauro; Tamborini, Gloria; Galli, C.; Barbier, P.; Doria, Elisabetta; Berti, Marco; Guazzi, Marco; Fiorentini, Cesare

doi:10.1016/s0894-7317(14)80414-8

Cited by 105 publications

(53 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Very frequently, in case of RV dilatation, the inferior vena cava also appears on a subcostal view as dilated and congestive without any respiratory movement. This reflects a high right atrial pressure [38].…”

Section: Evaluation Of Rv Sizementioning

confidence: 98%

Executive summary on the use of ultrasound in the critically ill: consensus report from the 3rd Course on Acute Care Ultrasound (CACU)

Malbrain¹,

Tavernier²,

Haverals³

et al. 2017

Anaesthesiol Intensive Ther

View full text Add to dashboard Cite

Over the past decades, ultrasound (US) has gained its place in the armamentarium of monitoring tools in the intensive care unit (ICU). Critical care ultrasonography (CCUS) is the combination of general CCUS (lung and pleural, abdominal, vascular) and CC echocardiography, allowing prompt assessment and diagnosis in combination with vascular access and therapeutic intervention. This review summarises the findings, challenges lessons from the 3 rd Course on Acute Care Ultrasound (CACU) held in November 2015, Antwerp, Belgium. It covers the different modalities of CCUS; touching on the various aspects of training, clinical benefits and potential benefits. Despite the benefits of CCUS, numerous challenges remain, including the delivery of CCUS training to future intensivists. Some of these are discussed along with potential solutions from a number of national European professional societies. There is a need for an international agreed consensus on what modalities are necessary and how best to deliver training in CCUS.

show abstract

Section: Evaluation Of Rv Sizementioning

confidence: 98%

Executive summary on the use of ultrasound in the critically ill: consensus report from the 3rd Course on Acute Care Ultrasound (CACU)

Malbrain¹,

Tavernier²,

Haverals³

et al. 2017

Anaesthesiol Intensive Ther

View full text Add to dashboard Cite

show abstract

“…The IVC collapsibility index (IVCCI) was measured by the following formula: [(maximal diameter of IVC on expiration -minimal diameter on inspiration)/(maximal diameter on expiration)] × 100 (6).…”

Section: Echocardiographic Examinationmentioning

confidence: 99%

Hypo- and hypervolemic edema in children with steroidsensitive nephrotic syndrome

Büyükavcı¹,

Çivilibal²,

Elevli³

et al. 2015

Turk J Med Sci

View full text Add to dashboard Cite

Background/aim: The mechanism of edema formation in nephrotic syndrome is still poorly understood. We aimed to evaluate the volume status in children with steroid-sensitive nephrotic syndrome (SSNS) and to emphasize the importance of echocardiography in demonstrating of volume changes.Materials and methods: Thirty-two SSNS patients and 30 healthy children were enrolled in this study. The volume statuses of patients were evaluated by clinical and laboratory features, including fractional sodium excretion (FENa) and distal sodium/potassium exchange (UK/UNa+K ratio). Inferior vena cava collapsibility index (IVCCI), left atrial diameter (LAD), aortic diameter (AD), and left ventricular mass index (LVMI) were measured using conventional echocardiographic methods.Results: FENa was lower in children with NS; however, the distal K/Na ratio of the patient and control groups did not differ. In addition, IVCCI, LAD, AD, and LVMI were not different among groups. When evaluating the volume status of patients, 8 patients (25%) were hypovolemic while 24 patients (75%) were nonhypovolemic (normovolemic or hypervolemic). LAD was significantly lower in hypovolemic patients. Conclusion:The majority of children with SSNS are normovolemic or hypervolemic and echocardiography is an easy and valuable method for the evaluation of volume status in these patients.

show abstract

“…Recording and measurements of Doppler-derived diastolic function were performed according to the recommendations of the American Society of Echocardiography (28). Pulmonary systolic arterial pressure was estimated by continuous wave Doppler as peak regurgitation velocity plus an assumed right atrial pressure in relation to the size and respiratory excursion of inferior cava vein visualized in subcostal view (42). A cut-off point value of pulmonary arterial systolic pressure of more than 25 mmHg was considered as diagnostic for arterial pulmonary hypertension.…”

Section: Echocardiographic Studymentioning

confidence: 99%

Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas

Auriemma¹,

Pivonello

Perone

et al. 2013

European Journal of Endocrinology

View full text Add to dashboard Cite

Objective: Cabergoline (CAB) has been found to be associated with increased risk of cardiac valve regurgitation in Parkinson's disease, whereas several retrospective analyses failed to detect a similar relation in hyperprolactinemic patients. The current study aimed at investigating cardiac valve disease before and after 24 and 60 months of continuous treatment with CAB only in patients with hyperprolactinemia. Subjects and methods: Forty patients (11 men and 29 women, aged 38.7G12.5 years) newly diagnosed with hyperprolactinemia entered the study. Cumulative CAB dose ranged from 12 to 588 mg (median 48 mg) at 24 months and 48-1260 mg (median 149 mg) at 60 months. All patients underwent a complete trans-thoracic echocardiographic examination. Valve regurgitation was assessed according to the American Society of Echocardiography. Results: At baseline, the prevalence of trace mitral, aortic, pulmonic, and tricuspid regurgitations was 20, 2.5, 10, and 40% respectively, with no patient showing clinically relevant valvulopathy. After 24 months, no change in the prevalence of trace mitral (PZ0.78) and pulmonic (PZ0.89) regurgitations and of mild aortic (PZ0.89) and tricuspid (PZ0.89) regurgitations was found when compared with baseline. After 60 months, the prevalence of trace tricuspid regurgitation was only slightly increased when compared with that after 24 months (37.5%; PZ0.82), but none of the patients developed significant valvulopathy. No correlation was found between cumulative dose and prevalence or grade of valve regurgitation at both evaluations. Prolactin levels normalized in all patients but one. Conclusion: CAB does not increase the risk of significant cardiac valve regurgitation in prolactinomas after the first 5 years of treatment.

show abstract

A New Formula For Echo-Doppler Estimation of Right Ventricular Systolic Pressure

Cited by 105 publications

References 12 publications

Executive summary on the use of ultrasound in the critically ill: consensus report from the 3rd Course on Acute Care Ultrasound (CACU)

Executive summary on the use of ultrasound in the critically ill: consensus report from the 3rd Course on Acute Care Ultrasound (CACU)

Hypo- and hypervolemic edema in children with steroidsensitive nephrotic syndrome

Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas

Contact Info

Product

Resources

About